Maksymilian Baryła

Mr. Maksymilian Baryła

Klinika Onkologii WUM
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 February 2022 in Biology
Verified
Journal Article
Open access
PDF file
MBMaksymilian Baryła
Maksymilian Baryła
ASAleksandra Semeniuk-Wojtaś
Aleksandra Semeniuk-Wojtaś
LRLetycja Róg
Letycja Róg
LKLeszek Kraj
Leszek Kraj
MMMaciej Małyszko
Maciej Małyszko
RSRafał Stec
Rafał Stec
The tumor microenvironment is the space between healthy tissues and cancer cells, created by the extracellular matrix, blood vessels, infiltrating cells such as immune cells, and cancer-associated fibroblasts. These components constantly interact and influence each other, enabling cancer cells to survive and develop in the host organism. Accumulated intermediate metabolites favoring dysregulation and compensatory responses in the cell, called oncometabolites, provide a method of communication between cells and might also play a role in cancer growth. Here, we describe the changes in metabolic pathways that lead to accumulation of intermediate metabolites: lactate, glutamate, fumarate, and succinate in the tumor and their impact on the tumor microenvironment. These oncometabolites are not only waste products, but also link all types of cells involved in tumor survival and progression. Oncometabolites play a particularly important role in neoangiogenesis and in the infiltration of immune cells in cancer. Oncometabolites are also associated with a disrupted DNA damage response and make the tumor microenvironment more favorable for cell migration. The knowledge summarized in this article will allow for a better understanding of associations between therapeutic targets and oncometabolites, as well as the direct effects of these particles on the formation of the tumor microenvironment. In the future, targeting oncometabolites could improve treatment standards or represent a novel method for fighting cancer.

2 July 2025 in Annals of Transplantation
Verified
Journal Article
Open access
MBMaksymilian Baryła
Maksymilian Baryła
MDMarcin Dymkowski
Marcin Dymkowski
JPJacek Pliszczynski
Jacek Pliszczynski
BACKGROUND Horseshoe kidney is a rare congenital anomaly, occurring in approximately 1 in 400 to 1 in 1800 individuals. When considering transplantation, horseshoe kidneys present unique challenges due to vascular and urinary tract anomalies. They can be transplanted either as a whole, en bloc unit or as 2 separate, split fragments. The complexities in vascular and urinary reconstruction require careful consideration to ensure successful transplantation. CASE REPORT We present a case involving the transplantation of a horseshoe kidney from a deceased 36-year-old male donor with confirmed brain death due to intracerebral bleeding. The kidney had a complex vascular arrangement, with 7 arteries, 2 veins, and 2 ureters. A surgical division and vascular reconstruction were performed. The kidney fragments were successfully transplanted into 64- and 65-year-old male recipients. Both grafts exhibited excellent reperfusion, and at 2-month follow-up, both patients demonstrated satisfactory graft function, without dialysis or acute rejection episodes. CONCLUSIONS In light of the ongoing shortage of kidney grafts, horseshoe kidneys represent a valuable yet challenging option for transplantation. While vascular and urinary tract anomalies can complicate their use, this case illustrates that, with meticulous surgical technique, horseshoe kidney transplantation can be both viable and safe. Nevertheless, the absence of standardized guidelines for splitting techniques and pre-procurement anatomical assessment underscores the need for further research and consensus in this area.

30 September 2023 in Lekarz Wojskowy
Verified
Journal Article
Closed access
RRRafał Roszkowski
Rafał Roszkowski
MBMaksymilian Baryła
Maksymilian Baryła
AKAndrzej Piotr Kwiatkowski
Andrzej Piotr Kwiatkowski
Introduction: Gastric cancer is the fifth most common cancer worldwide. Surgery or endoscopic treatment is essential in all disease stages. The most common procedure is total gastrectomy with D2 lymphadenectomy. Removal of stomach and lymph nodes can be performed using minimally invasive...

11 December 2025 in American Journal of Case Reports
Verified
Journal Article
Open access
MBMaksymilian Baryła
Maksymilian Baryła
PZPaweł Kazimierz Ziemiański
Paweł Kazimierz Ziemiański
BACKGROUND The right and left gastroepiploic arteries supply the stomach and greater omentum. The right gastroepiploic artery originates from the gastroduodenal artery and runs along the greater curvature of the stomach. Aneurysms of the gastroepiploic arteries are rare; however, despite their low incidence, their rupture is associated with a mortality rate of up to 70%. Management options for gastroepiploic artery aneurysms include open surgery, endovascular techniques, and laparoscopic procedures. This report presents the case of a 60-year-old man with an incidentally discovered, asymptomatic aneurysm of the right gastroepiploic artery, managed successfully by laparoscopic resection. CASE REPORT A 60-year-old man was incidentally diagnosed with a right gastroepiploic artery aneurysm during a computed tomography scan. The patient was asymptomatic, reporting no abdominal pain or other clinical signs. He had no history of gastrointestinal bleeding, either from the upper or lower tract. The patient was admitted to the Department of General and Transplant Surgery. Laparoscopic resection of the aneurysm was proposed and performed as definitive treatment. The operative and postoperative courses were uneventful. Histopathological examination did not reveal any lesions suggestive of genetic or connective tissue disorders. CONCLUSIONS This case describes a rare presentation of an asymptomatic aneurysm of the right gastroepiploic artery, which was successfully managed with laparoscopic resection. Laparoscopic management may offer a safe and effective alternative for treating asymptomatic, non-ruptured gastroepiploic artery aneurysms. Compared with noninvasive methods, laparoscopy provides a minimally invasive yet definitive approach and can be particularly beneficial in patients with tortuous vasculature, obesity, or multiple comorbidities.

8 March 2026 in American Journal of Case Reports
Verified
Journal Article
Open access
OWOliwia Wicik
Oliwia Wicik
MBMaksymilian Baryła
Maksymilian Baryła
JPJacek Pliszczyński
Jacek Pliszczyński
APAleksandra Popławska-Ferenc
Aleksandra Popławska-Ferenc
BACKGROUND Marfan syndrome is a multisystemic, autosomal dominant connective tissue disorder caused by mutations in the fibrillin-1 gene. It is associated with life-threatening complications, especially aortic aneurysms and dissections, and has a global prevalence of 1 in 3000-5000 individuals. Although kidney transplantation is the standard treatment for end-stage renal disease (ESRD), deceased kidney donors with Marfan syndrome remain uncommon due to concerns about connective tissue fragility. Emerging reports, however, indicate that kidneys from such donors may be safely used. This report describes 2 successful kidney transplantations from a 39-year-old male donor with confirmed Marfan syndrome. CASE REPORT Case 1. The donor died from subarachnoid hemorrhage and had a history of aortic arch replacement for aortic dissection. Both kidneys were retrieved from the retroperitoneal space, prepared according to standard protocols, and stored in University of Wisconsin Store Protect Plus organ preservation solution under static cold storage at 4°C. Case 2. A 59-year-old man with ESRD secondary to diabetic nephropathy underwent his first kidney transplantation. He was hemodialyzed with residual diuresis. The right kidney was transplanted without complications, and the recipient achieved immediate and stable graft function. Case 3. The second recipient was a 34-year-old man with ESRD due to vesicoureteral reflux and obstructive nephropathy, also on hemodialysis with preserved diuresis. Left kidney transplantation proceeded uneventfully. He experienced delayed graft function, which resolved with appropriate management, resulting in satisfactory renal recovery. CONCLUSIONS These cases support the growing evidence that kidneys from donors with Marfan syndrome can function effectively after transplantation. Such donors may represent a valuable and underutilized resource, with the potential to expand the kidney donor pool safely.